Human Reproduction, Vol. 15, No. 3, 637-645,
March 2000
© 2000 European Society of Human Reproduction and Embryology
Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations
1 Contraceptive Development Network at Department of Obstetrics and Gynaecology, University of Edinburgh, 2 MRC Reproductive Biology Unit, Centre for Reproductive Biology, Edinburgh, UK, 3 Institute of Family Planning and Technical Instruction, 145 Guangyuan Road, Shanghai, People's Republic of China, 4 Department of Obstetrics and Gynaecology, University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong and 5 Department of Obstetrics and Gynaecology, University of Cape Town, Anzio Road, Cape Town, South Africa
The prospect of a hormonal male contraceptive is no longer distant. Data on the potential impact of this improvement in contraceptive provision, however, is limited, particularly between different cultures. We have therefore carried out a multi-centre study to assess men's attitudes to proposed novel hormonal methods. Questionnaire-based structured interviews were administered to men in Edinburgh, Cape Town, Shanghai and Hong Kong. Approximately 450 men were interviewed in Edinburgh, Shanghai and Hong Kong, and a slightly larger group (n = 493) in Cape Town to give samples (n > 150) of black, coloured and white men. Knowledge of existing male and female methods of contraception was high in all centres and groups. The majority of men welcomed a new hormonal method of contraception, 44–83% stating that they would use a male contraceptive pill. Overall, a pill was more acceptable than an injectable form (most popularly given at 3–6 month intervals); long-acting implants were least so except in Shanghai. Familiarity with comparable female methods appeared to influence acceptability, for both oral and injectable methods. Hong Kong was the only centre where a male method (condom) was currently the most commonly used; men there appeared to rate the convenience of condoms highly while being least likely to think that they provided effective protection against pregnancy compared to other centres, and were least enthusiastic about novel male methods. The acceptability of potential male hormonal methods of contraception was high in some groups but showed wide variability, determining factors including cultural background and current contraceptive usage. These results suggest that the emerging emphasis that men should have greater involvement in family planning will be substantiated when appropriate contraceptive methods become available.
Key words: acceptability/attitudes/cultural setting/knowledge/male contraception
6 To whom correspondence should be addressed at: MRC Reproductive Biology Unit, Centre for Reproductive Biology, University of Edinburgh, 37 Chalmers St, Edinburgh EH3 9ET, UK
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P Sipila, J Jalkanen, I T Huhtaniemi, and M Poutanen Novel epididymal proteins as targets for the development of post-testicular male contraception Reproduction, March 1, 2009; 137(3): 379 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mommers, W. M. Kersemaekers, J. Elliesen, M. Kepers, D. Apter, H. M. Behre, J. Beynon, P. M. Bouloux, A. Costantino, H.-P. Gerbershagen, et al. Male Hormonal Contraception: A Double-Blind, Placebo-Controlled Study J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2572 - 2580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Page, J. K. Amory, and W. J. Bremner Advances in Male Contraception Endocr. Rev., June 1, 2008; 29(4): 465 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Amory, T. F. Kalhorn, and S. T. Page Pharmacokinetics and Pharmacodynamics of Oral Testosterone Enanthate Plus Dutasteride for 4 Weeks in Normal Men: Implications for Male Hormonal Contraception J Androl, May 1, 2008; 29(3): 260 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.C. Meriggiola, S. Cerpolini, W.J. Bremner, M.T. Mbizvo, K.M. Vogelsong, G. Martorana, and G. Pelusi Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men Hum. Reprod., August 1, 2006; 21(8): 2033 - 2040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Matthiesson and R. I. McLachlan Male hormonal contraception: concept proven, product in sight? Hum. Reprod. Update, July 1, 2006; 12(4): 463 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Di Zhang and M. Gopalakrishnan Sperm Ion Channels: Molecular Targets for the Next Generation of Contraceptive Medicines? J Androl, November 1, 2005; 26(6): 643 - 653. [Full Text] [PDF]
|
|
|
|
|
|
A. V. Marcell, K. Plowden, and S. M. Bowman Exploring older adolescents' and young adults' attitudes regarding male hormonal contraception: applications for clinical practice Hum. Reprod., November 1, 2005; 20(11): 3078 - 3084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Heinemann, F. Saad, M. Wiesemes, and L. A. J. Heinemann Expectations Toward a Novel Male Fertility Control Method and Potential User Types: Results of a Multinational Survey J Androl, March 1, 2005; 26(2): 155 - 162. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen, D. J. Hwang, C. E. Bohl, D. D. Miller, and J. T. Dalton A Selective Androgen Receptor Modulator for Hormonal Male Contraception J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 546 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Heinemann, F. Saad, M. Wiesemes, S. White, and L. Heinemann Attitudes toward male fertility control: results of a multinational survey on four continents Hum. Reprod., February 1, 2005; 20(2): 549 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.M. Brady, M. Walton, N. Hollow, A.T. Kicman, D.T. Baird, and R.A. Anderson Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception Hum. Reprod., November 1, 2004; 19(11): 2658 - 2667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-L. Gui, C.-H. He, J. K. Amory, W. J. Bremner, E-X. Zheng, J. Yang, P.-J. Yang, and E.-S. Gao Male Hormonal Contraception: Suppression of Spermatogenesis by Injectable Testosterone Undecanoate Alone or With Levonorgestrel Implants in Chinese Men J Androl, September 1, 2004; 25(5): 720 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Turner, A. J. Conway, M. Jimenez, P. Y. Liu, E. Forbes, R. I. McLachlan, and D. J. Handelsman Contraceptive Efficacy of a Depot Progestin and Androgen Combination in Men J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4659 - 4667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Meriggiola, T. M.M. Farley, and M. T. Mbizvo A Review of Androgen-Progestin Regimens for Male Contraception J Androl, July 1, 2003; 24(4): 466 - 483. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Handelsman Hormonal Male Contraception--Lessons from the East When the Western Market Fails J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 559 - 561. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Anderson and D. T. Baird Male Contraception Endocr. Rev., December 1, 2002; 23(6): 735 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.A. Anderson, Z.M. van der Spuy, O.A. Dada, S.K. Tregoning, P.M. Zinn, O.A. Adeniji, T.A. Fakoya, K.B. Smith, and D.T. Baird Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone Hum. Reprod., November 1, 2002; 17(11): 2869 - 2877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kinniburgh, H. Zhu, L. Cheng, A.T. Kicman, D.T. Baird, and R.A. Anderson Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men Hum. Reprod., June 1, 2002; 17(6): 1490 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kamischke, T. Heuermann, K. Kruger, S. von Eckardstein, I. Schellschmidt, A. Rubig, and E. Nieschlag An Effective Hormonal Male Contraceptive Using Testosterone Undecanoate with Oral or Injectable Norethisterone Preparations J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 530 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Martin, S. C. Riley, D. Everington, N. P. Groome, R. A. Riemersma, D. T. Baird, and R. A. Anderson Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men Hum. Reprod., July 1, 2000; 15(7): 1515 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.F. Glasier, R. Anakwe, D. Everington, C.W. Martin, Z.v. d. Spuy, L. Cheng, P.C. Ho, and R.A. Anderson Would women trust their partners to use a male pill? Hum. Reprod., March 1, 2000; 15(3): 646 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kamischke, S. Venherm, D. Plöger, S. von Eckardstein, and E. Nieschlag Intramuscular Testosterone Undecanoate and Norethisterone Enanthate in a Clinical Trial for Male Contraception J. Clin. Endocrinol. Metab., January 1, 2000; 86(1): 303 - 309. [Abstract] [Full Text]
|
|